You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult T cell Leukemia-Lymphoma (ATL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Survival of Adult T-cell Leukemia / Lymphoma and Patients

Recruiting
  • Lymphoproliferation Induced by HTLV-1
  • +2 more
    • Paris, France
      Hôpital Necker Enfants Malades
    Sep 26, 2022

    T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

    Completed
    Has Results
    • T-Cell Lymphoma Relapsed
    • +4 more
    • IL-15 plus
    • alemtuzumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 27, 2022

    Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

    Recruiting
    • Acute Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Atlanta, Georgia
    • +13 more
    Jan 26, 2023

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,

      Completed
      • T Cell Leukemia, Adult
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 26, 2022

      Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

      Active, not recruiting
      Has Results
      • Adult T-Cell Leukemia (ATL)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 13, 2022

      T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • CD7 CAR-T cells
      • Shenzhen, Guangdong, China
        Li Yu
      Nov 11, 2022

      Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

      Recruiting
      • Extranodal NK T Cell Lymphoma
      • NK-Cell Leukemia
      • Anti-CD56 CAR T
      • Xuzhou, Jiangsu, China
        The Affiliated Hospital of Xuzhou Medical University
      Jul 10, 2023

      T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

      Not yet recruiting
      • T-Cell Non-Hodgkin Lymphoma
      • +14 more
      • WU-CART-007
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 17, 2023

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)

      Active, not recruiting
      • Lymphoma
      • +2 more
      • Brentuximab Vedotin
      • CHEP
      • Hollywood, Florida
      • +3 more
      Nov 30, 2022

      T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

      Terminated
      • T-Acute Lymphoblastic Leukemia
      • Adult T Lymphoblastic Lymphoma
      • Saint Louis, Missouri
      • +1 more
      Jan 18, 2023

      Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

      Recruiting
      • Recurrent Adult T-Cell Leukemia/Lymphoma
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Nov 18, 2022

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

      Recruiting
      • B-Cell Non Hodgkin Lymphoma
      • B-Cell Acute Lymphoblastic Leukemia
      • anti-CD19 CAR T-cells
      • Hanoi, Vietnam
        Vinmec Research Institute of Stem Cell and Gene Technology
      Sep 5, 2023

      T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

      Withdrawn
      • T-cell Acute Lymphoblastic Leukemia
      • T-lymphoblastic Lymphoma
      • Target CD7 CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force of People's Libe
      Nov 23, 2022

      B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • +2 more
      • CD19/CD22-bispecific CAR-T cells
      • Beijing, Beijing, China
        Liang Wang
      Oct 7, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      Aug 7, 2023

      T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

      Recruiting
      • T-cell Lymphoma
      • +30 more
      • Optional Blood Sample
      • Optional Nail Sample
      • Duarte, California
      • +25 more
      Jul 28, 2023

      Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

      Completed
      Has Results
      • Adult T-Cell Lymphoma/Leukemia
      • +2 more
      • Recombinant human Interleukin-15 (rhIL-15)
      • Mogamulizumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 9, 2022

      Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

      Recruiting
      • Non Hodgkin Lymphoma (NHL)
      • +4 more
      • Orange, California
      • +8 more
      Nov 29, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Miltenyi CliniMACS Prodigy ® system
      • (no location specified)
      Mar 23, 2023

      T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

      Recruiting
      • T-Cell Acute Lymphocytic Leukemia
      • CD7 CAR-T
      • Langfang, Hebei, China
        Hebei Yanda Hospital
      Jun 26, 2023

      B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Unspecified Trial in Guangzhou, Guanzhou (CD19 CAR T-Cell(CAT19T2))

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • B-Cell Lymphoma, Unspecified
      • CD19 CAR T-Cell(CAT19T2)
      • Guangzhou, Guangdong, China
      • +1 more
      Nov 4, 2022